Narrative review / 2004
Evidence from randomized controlled trials does not justify the use of DHEA in healthy elderly individuals.
This review evaluates the role of dehydroepiandrosterone (DHEA) in ageing and other conditions. Convincing evidence exists for beneficial effects of DHEA in patients with adrenal insufficiency. However, in healthy elderly subjects, current evidence from randomized controlled trials does not justify DHEA use, as no major beneficial effects have been reported and potential risks regarding sex steroid-dependent tumour growth must be considered.
- Study type
- Review
- Who was studied
- Healthy elderly subjects and patients with adrenal insufficiency
- What was measured
- Anti-ageing effects, clinical benefits, and adverse effects of DHEA
THE PAPER
Dehydroepiandrosterone and ageing.
Arlt W. Best Pract Res Clin Endocrinol Metab, 2004.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.